Literature DB >> 24879507

Novel assessment tools for osteoporosis diagnosis and treatment.

Bo Gong1, Gurjit S Mandair, Felix W Wehrli, Michael D Morris.   

Abstract

This review describes new technologies for the diagnosis and treatment, including fracture risk prediction, of postmenopausal osteoporosis. Four promising technologies and their potential for clinical translation and basic science studies are discussed. These include reference point indentation (RPI), Fourier transform infrared spectroscopy (FTIR), Raman spectroscopy, and magnetic resonance imaging (MRI). While each modality exploits different physical principles, the commonality is that none of them require use of ionizing radiation. To provide context for the new developments, brief summaries are provided for the current state of biomarker assays, fracture risk assessment (FRAX), and other fracture risk prediction algorithms and quantitative ultrasound (QUS) measurements.

Entities:  

Mesh:

Year:  2014        PMID: 24879507      PMCID: PMC6218937          DOI: 10.1007/s11914-014-0215-2

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  98 in total

Review 1.  Assessment of fracture risk.

Authors:  Sanford Baim; William D Leslie
Journal:  Curr Osteoporos Rep       Date:  2012-03       Impact factor: 5.096

2.  Femoral neck cortical geometry measured with magnetic resonance imaging is associated with proximal femur strength.

Authors:  S L Manske; T Liu-Ambrose; P M de Bakker; D Liu; S Kontulainen; P Guy; T R Oxland; H A McKay
Journal:  Osteoporos Int       Date:  2006-07-18       Impact factor: 4.507

3.  Reference-point indentation correlates with bone toughness assessed using whole-bone traditional mechanical testing.

Authors:  Maxime A Gallant; Drew M Brown; Jason M Organ; Matthew R Allen; David B Burr
Journal:  Bone       Date:  2012-12-27       Impact factor: 4.398

4.  Micro OS-ELISA: Rapid noncompetitive detection of a small biomarker peptide by open-sandwich enzyme-linked immunosorbent assay (OS-ELISA) integrated into microfluidic device.

Authors:  Masaki Ihara; Amane Yoshikawa; Yushu Wu; Hiroko Takahashi; Kazuma Mawatari; Kiyohito Shimura; Kae Sato; Takehiko Kitamori; Hiroshi Ueda
Journal:  Lab Chip       Date:  2009-11-03       Impact factor: 6.799

5.  Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study.

Authors:  Charles H Chesnut; Sharmilla Majumdar; David C Newitt; Andrew Shields; Jan Van Pelt; Ellen Laschansky; Moise Azria; Audrey Kriegman; Melvin Olson; Erik F Eriksen; Linda Mindeholm
Journal:  J Bone Miner Res       Date:  2005-04-27       Impact factor: 6.741

6.  Effects of 3 years treatment with once-yearly zoledronic acid on the kinetics of bone matrix maturation in osteoporotic patients.

Authors:  S Gamsjaeger; B Hofstetter; E Zwettler; R Recker; J A Gasser; E F Eriksen; K Klaushofer; E P Paschalis
Journal:  Osteoporos Int       Date:  2012-11-15       Impact factor: 4.507

7.  Identifying postmenopausal women with osteoporosis by calcaneal ultrasound, metacarpal digital X-ray radiogrammetry and phalangeal radiographic absorptiometry: a comparative study.

Authors:  Steven Boonen; Jos Nijs; Herman Borghs; Herman Peeters; Dirk Vanderschueren; Frank P Luyten
Journal:  Osteoporos Int       Date:  2004-06-10       Impact factor: 4.507

8.  Bone marrow fat composition as a novel imaging biomarker in postmenopausal women with prevalent fragility fractures.

Authors:  Janina M Patsch; Xiaojuan Li; Thomas Baum; Samuel P Yap; Dimitrios C Karampinos; Ann V Schwartz; Thomas M Link
Journal:  J Bone Miner Res       Date:  2013-08       Impact factor: 6.741

9.  Use of FTIR spectroscopic imaging to identify parameters associated with fragility fracture.

Authors:  Samuel Gourion-Arsiquaud; Dan Faibish; Elizabeth Myers; Lyudmila Spevak; Juliet Compston; Anthony Hodsman; Elizabeth Shane; Robert R Recker; Elizabeth R Boskey; Adele L Boskey
Journal:  J Bone Miner Res       Date:  2009-09       Impact factor: 6.741

10.  International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis.

Authors:  Samuel Vasikaran; Cyrus Cooper; Richard Eastell; Andrea Griesmacher; Howard A Morris; Tommaso Trenti; John A Kanis
Journal:  Clin Chem Lab Med       Date:  2011-05-24       Impact factor: 3.694

View more
  7 in total

1.  Assessment of collagen quality associated with non-enzymatic cross-links in human bone using Fourier-transform infrared imaging.

Authors:  F N Schmidt; E A Zimmermann; G M Campbell; G E Sroga; K Püschel; M Amling; S Y Tang; D Vashishth; B Busse
Journal:  Bone       Date:  2017-01-18       Impact factor: 4.398

Review 2.  Vibrational spectroscopic techniques to assess bone quality.

Authors:  E P Paschalis; S Gamsjaeger; K Klaushofer
Journal:  Osteoporos Int       Date:  2017-04-05       Impact factor: 4.507

3.  What is changed in the diagnosis of osteoporosis: the role of radiologists.

Authors:  Giuseppe Guglielmi; Rosario Francesco Balzano; Xiaoguang Cheng
Journal:  Quant Imaging Med Surg       Date:  2018-02

Review 4.  Osteoporosis: what the clinician needs to know?

Authors:  Rosario Francesco Balzano; Maria Mattera; Xiaoguang Cheng; Samantha Cornacchia; Giuseppe Guglielmi
Journal:  Quant Imaging Med Surg       Date:  2018-02

Review 5.  Fracture prediction, imaging and screening in osteoporosis.

Authors:  Nicholas R Fuggle; Elizabeth M Curtis; Kate A Ward; Nicholas C Harvey; Elaine M Dennison; Cyrus Cooper
Journal:  Nat Rev Endocrinol       Date:  2019-09       Impact factor: 43.330

6.  Added Value of Impact Microindentation in the Evaluation of Bone Fragility: A Systematic Review of the Literature.

Authors:  Manuela Schoeb; Neveen A T Hamdy; Frank Malgo; Elizabeth M Winter; Natasha M Appelman-Dijkstra
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-07       Impact factor: 5.555

7.  Altered levels of BMD, PRL, BAP and TRACP-5b in male chronic patients with schizophrenia.

Authors:  Xiangdong Du; Fei Ye; Jin Li; Yaqin Zhao; Wenhuan Xiao; Xiaowei Tang; Xiaobin Zhang
Journal:  Sci Rep       Date:  2020-08-12       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.